Cepheid UK Limited is a limited company established in 2002, operating from Unit 4 Blythe Valley Innovation Centre, Central Boulevard, Solihull, B90 8AJ. As a registered SIC code of -46190, Cepheid specializes in the design, development, and manufacture of highly sensitive DNA sequencing and analysis instruments. The company focuses on providing cutting-edge diagnostic solutions primarily within the healthcare sector. Cepheid’s core business centers around enabling rapid and accurate molecular diagnostics, particularly in oncology and inherited diseases. Their instruments are utilized for identifying genetic mutations that drive disease, facilitating personalized medicine and improving patient outcomes. The company’s products are critical for early disease detection, treatment planning, and monitoring. Cepheid’s services encompass instrument sales, maintenance, and support, alongside custom sequencing solutions tailored to specific client needs. They cater to a diverse range of clients, including research institutions, pharmaceutical companies, and clinical laboratories globally. The company’s international presence is significant, with operations and partnerships extending across Europe and North America. Cepheid’s key focus is on expanding access to molecular diagnostics through its technology, ultimately improving patient care.

Cepheid UK Limited is a limited company established in 2002, operating from Unit 4 Blythe Valley Innovation Centre, Central Boulevard, Solihull, B90 8AJ. As a registered SIC code of -46190, Cepheid specializes in the design, development, and manufacture of highly sensitive DNA sequencing and analysis instruments. The company focuses on providing cutting-edge diagnostic solutions primarily within the healthcare sector. Cepheid’s core business centers around enabling rapid and accurate molecular diagnostics, particularly in oncology and inherited diseases. Their instruments are utilized for identifying genetic mutations that drive disease, facilitating personalized medicine and improving patient outcomes. The company’s products are critical for early disease detection, treatment planning, and monitoring. Cepheid’s services encompass instrument sales, maintenance, and support, alongside custom sequencing solutions tailored to specific client needs. They cater to a diverse range of clients, including research institutions, pharmaceutical companies, and clinical laboratories globally. The company’s international presence is significant, with operations and partnerships extending across Europe and North America. Cepheid’s key focus is on expanding access to molecular diagnostics through its technology, ultimately improving patient care.